Skip to content
Screener

Vericel VCEL Shares (Diluted)

Shares (Diluted) at other companies

Stryker logo
StrykerSYK
386M-0.1%
CONMED logo
CONMEDCNMD
30.1M-3.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
192.8M-2.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
24.5M+7.2%
MiMedx Group logo
MiMedx GroupMDXG
147.8M-1.0%
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
128.7M+1.4%

Other financials

Income statement

See full
Revenue$77.5M+22.5%
Gross profit$56.4M+21.0%
Operating income$434.0K+121%
Net income$2.2M+499%
EPS (diluted)$0.04+500%

Balance sheet

See full
Cash & equivalents$125.4M+55.7%
Total debt$93.1M-7.3%
Total equity$370.0M+20.6%
Total assets$502.9M+15.4%

Cash flow

See full
Operating cash flow$16.2M+97.1%
CapEx$1.9M-76.2%
Free cash flow$14.3M+17,504%

Valuation

See full
Market cap$2.31B+29.1%
Enterprise value$2.28B+25.9%
P/E95.3×-156×
P/S7.5×+0.4×

Profitability

See full
Gross margin74.6%+1.1pp
Operating margin6%+5.5pp
Net margin7.9%+5.1pp
FCF margin20.1%

Returns & leverage

See full
Return on equity7.2%+4.6pp
Debt / equity0.3×-0.1×
Current ratio+0.1×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Vericel’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 8:49 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-050836
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total other income1,7721,4763,5343,022
Net income (loss)$2,206$(553)$(4,096)$(11,799)
Net income (loss) per common share:
Basic$0.04$(0.01)$(0.08)$(0.24)
Diluted$0.04$(0.01)$(0.08)$(0.24)
Weighted-average common shares outstanding:
Basic51,07550,36850,92550,138
Diluted52,31250,36850,92550,138

Item 1. Financial Statements (Unaudited)

FAQ

What is Vericel's shares (diluted)?
Vericel (VCEL) reported shares (diluted) of 52.3M in Q2 2026.
How has Vericel's shares (diluted) changed year-over-year?
Vericel's shares (diluted) increased by 3.9% year-over-year, from 50.4M to 52.3M.
What is the long-term trend for Vericel's shares (diluted)?
Over 4 years (2021 to 2025), Vericel's shares (diluted) has grown at a 2.4% compound annual growth rate (CAGR), from 185.5M to 204.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Vericel's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude